Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, randomized, parallel group comparison study to verify the
clinical equivalency of the old formulation (50 mcg as mometasone furoate [MF] in 50 μL of
solution per spray) to the new formulation (50 mcg as MF in 100 μL of solution per spray) in
patients with perennial allergic rhinitis.